topiramate and semaglutide Is a GLP-1? Weight Loss Drug Differences Old and new anti-obesity drugs

Thats the heart of glow-from-within

Our programs are designed to help patients lose weight safely while improving overall wellness and quality of life

Food and Drug Administration , 2025

Other side effects Additional reported side effects include: Joint pain and water retention Muscle and joint aches Headaches and nausea Receptor desensitization with prolonged use Potential suppression of natural GH and IGF-1 production Who should avoid IGF-1 LR3 Certain groups should not use IGF-1 LR3: Anyone with active cancer or tumor history Those with severe insulin resistance or diabetes Pregnant or nursing women Anyone under 25 whose growth plates haven't closed Those with existing hormonal imbalances IGF-1 LR3 is not FDA-approved for general medical use and remains primarily a research compound